A detailed history of First Citizens Bank & Trust CO transactions in Adma Biologics, Inc. stock. As of the latest transaction made, First Citizens Bank & Trust CO holds 39,187 shares of ADMA stock, worth $609,749. This represents 0.01% of its overall portfolio holdings.

Number of Shares
39,187
Previous 40,050 2.15%
Holding current value
$609,749
Previous $729,000 21.26%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

SELL
$14.66 - $19.91 $12,651 - $17,182
-863 Reduced 2.15%
39,187 $574,000
Q2 2025

Jul 30, 2025

BUY
$17.6 - $24.51 $470,835 - $655,691
26,752 Added 201.17%
40,050 $729,000
Q1 2025

Apr 14, 2025

BUY
$15.44 - $20.61 $205,321 - $274,071
13,298 New
13,298 $269,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.06B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track First Citizens Bank & Trust CO Portfolio

Follow First Citizens Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.